Cargando…
Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study
BACKGROUND: Axillary hyperpigmentation is a frequent cause of cosmetic consultations in dark-skinned women from tropical areas, including Latin America. Currently, there is no widely accepted treatment for the disorder, but it is usually treated with bleaching agents because it is considered a varia...
Autores principales: | Castanedo-Cazares, Juan Pablo, Lárraga-Piñones, Gabryela, Ehnis-Pérez, Adriana, Fuentes-Ahumada, Cornelia, Oros-Ovalle, Cuauhtemoc, Smoller, Bruce R, Torres-Álvarez, Bertha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552481/ https://www.ncbi.nlm.nih.gov/pubmed/23355788 http://dx.doi.org/10.2147/CCID.S39246 |
Ejemplares similares
-
DNA Methyltransferases in Malar Melasma and Their Modification by Sunscreen in Combination with 4% Niacinamide, 0.05% Retinoic Acid, or Placebo
por: Campuzano-García, Andres Eduardo, et al.
Publicado: (2019) -
A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma
por: Navarrete-Solís, Josefina, et al.
Publicado: (2011) -
Metastatic Calcinosis Cutis: A Case in a Child with Acute Pre-B Cell Lymphoblastic Leukemia
por: Castanedo-Cázares, Juan Pablo, et al.
Publicado: (2015) -
Suppression of toxicity of the mutant huntingtin protein by its interacting compound, desonide
por: Song, Haikun, et al.
Publicado: (2022) -
Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019)